Company: HYEX
Filing Date: 2025-04-01
Form Type: 10-K
Source: 0001096906-25-000370
Chunk: 65

Company: HEALTHY EXTRACTS INC.
Filing Date: 2025-04-01
Form: 10-K
Item: Item 1A
Chunk 65
---
 has abated; 

·if the future market price of our Common Stock declines, holders of shares of Common Stock may be unable to resell such shares at or above the price at which they acquired them. We cannot assure such holders that the market of our Common Stock will not fluctuate or decline significantly in the future, in which case investors could incur substantial losses. 

Further, we may incur rapid and substantial increases or decreases in our Common Stock price in the foreseeable future that may not coincide in timing with the disclosure of news or developments by or affecting us. Accordingly, the market price of our Common Stock may fluctuate dramatically, and may decline rapidly, regardless of any developments in our business. Overall, there are various factors, many of which are beyond our control, that could negatively affect the market price of our Common Stock or result in fluctuations in the price or trading volume of our Common Stock, including:

·actual or anticipated variations in our annual or quarterly results of operations, including our earnings estimates and whether we meet market expectations with regard to our earnings; 

·our current inability to pay dividends or other distributions; 

·publication of research reports by analysts or others about us or the industry in which we operate, including the nutraceutical industry which may be unfavorable, inaccurate, inconsistent or not disseminated on a regular basis; 

·changes in market valuations of similar companies; 

·market reaction to any additional equity, debt or other securities that we may issue in the future, and which may or may not dilute the holdings of our existing stockholders; 

·additions or departures of key personnel; 

·actions by institutional or significant stockholders; 

·short interest in our Common Stock or our other securities and the market response to such short interest; 

·the dramatic increase in the number of individual holders of our Common Stock and their participation in social media platforms targeted at speculative investing; 

·speculation in the press or investment community about our company or industries in which we operate; 

·strategic actions by us or our competitors, such as acquisitions or other investments; 

·legislative, administrative, regulatory or other actions affecting our business, our industry, including positions taken by the FDA; 

·investigations, proceedings, or litigation that involve or affect us; 

·the occurrence of any of the other risk factors included in this annual report; and 

·general market and economic conditions. 

A significant portion